Phosphoinositide 3-kinase inhibitor
Description Results NMA

Alpelisib - Taselisib      

  • Group by...

pathologytreatmentpatient Demonstrated benefit and harm k      
advanced breast cancer (metastatic)taselisib2L ER PIK3CA-MUT

versus endocrine therapy alone

No demonstrated result for efficacy

1 trialmeta-analysis



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons